812 related articles for article (PubMed ID: 20937945)
21. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
Siwek T; Jezierska-Woźniak K; Maksymowicz S; Barczewska M; Sowa M; Badowska W; Maksymowicz W
Med Sci Monit; 2020 Dec; 26():e927484. PubMed ID: 33301428
[TBL] [Abstract][Full Text] [Related]
22. Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial.
Nabavi SM; Arab L; Jarooghi N; Bolurieh T; Abbasi F; Mardpour S; Azimyian V; Moeininia F; Maroufizadeh S; Sanjari L; Hosseini SE; Aghdami N
Cell J; 2019 Jan; 20(4):592-598. PubMed ID: 30124008
[TBL] [Abstract][Full Text] [Related]
23. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes.
Feldman EL; Boulis NM; Hur J; Johe K; Rutkove SB; Federici T; Polak M; Bordeau J; Sakowski SA; Glass JD
Ann Neurol; 2014 Mar; 75(3):363-73. PubMed ID: 24510776
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis.
Tavakol-Afshari J; Boroumand AR; Farkhad NK; Adhami Moghadam A; Sahab-Negah S; Gorji A
Regen Ther; 2021 Dec; 18():268-274. PubMed ID: 34466632
[TBL] [Abstract][Full Text] [Related]
25. The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study.
Shamsaei G; Houshmand F; Ahmadzadeh Deylami A; Valizadeh A; Rafie S; Moradi M
Adv Pharm Bull; 2023 Mar; 13(2):361-367. PubMed ID: 37342380
[No Abstract] [Full Text] [Related]
26. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.
Mazzini L; Gelati M; Profico DC; Sorarù G; Ferrari D; Copetti M; Muzi G; Ricciolini C; Carletti S; Giorgi C; Spera C; Frondizi D; Masiero S; Stecco A; Cisari C; Bersano E; De Marchi F; Sarnelli MF; Querin G; Cantello R; Petruzzelli F; Maglione A; Zalfa C; Binda E; Visioli A; Trombetta D; Torres B; Bernardini L; Gaiani A; Massara M; Paolucci S; Boulis NM; Vescovi AL;
Stem Cells Transl Med; 2019 Sep; 8(9):887-897. PubMed ID: 31104357
[TBL] [Abstract][Full Text] [Related]
27. Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis.
Politi LS; Bacigaluppi M; Brambilla E; Cadioli M; Falini A; Comi G; Scotti G; Martino G; Pluchino S
Stem Cells; 2007 Oct; 25(10):2583-92. PubMed ID: 17600110
[TBL] [Abstract][Full Text] [Related]
28. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.
Llufriu S; Sepúlveda M; Blanco Y; Marín P; Moreno B; Berenguer J; Gabilondo I; Martínez-Heras E; Sola-Valls N; Arnaiz JA; Andreu EJ; Fernández B; Bullich S; Sánchez-Dalmau B; Graus F; Villoslada P; Saiz A
PLoS One; 2014; 9(12):e113936. PubMed ID: 25436769
[TBL] [Abstract][Full Text] [Related]
29. In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T.
Zhang R; Li J; Xin L; Xie J
Ren Fail; 2015; 37(8):1363-9. PubMed ID: 26248484
[TBL] [Abstract][Full Text] [Related]
30. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.
Riordan NH; Morales I; Fernández G; Allen N; Fearnot NE; Leckrone ME; Markovich DJ; Mansfield D; Avila D; Patel AN; Kesari S; Paz Rodriguez J
J Transl Med; 2018 Mar; 16(1):57. PubMed ID: 29523171
[TBL] [Abstract][Full Text] [Related]
31. Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
Nabavi SM; Karimi SH; Arab L; Sanjari L; Mardpour S; Azimian V; Jarughi N; Ghaheri A; Hosseini SE; Aghdami N; Vosough M
Cell J; 2021 Dec; 23(7):772-778. PubMed ID: 34979067
[TBL] [Abstract][Full Text] [Related]
32. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.
Bonab MM; Sahraian MA; Aghsaie A; Karvigh SA; Hosseinian SM; Nikbin B; Lotfi J; Khorramnia S; Motamed MR; Togha M; Harirchian MH; Moghadam NB; Alikhani K; Yadegari S; Jafarian S; Gheini MR
Curr Stem Cell Res Ther; 2012 Nov; 7(6):407-14. PubMed ID: 23061813
[TBL] [Abstract][Full Text] [Related]
33. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
Trials; 2019 May; 20(1):263. PubMed ID: 31072380
[TBL] [Abstract][Full Text] [Related]
34. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
Riley J; Federici T; Polak M; Kelly C; Glass J; Raore B; Taub J; Kesner V; Feldman EL; Boulis NM
Neurosurgery; 2012 Aug; 71(2):405-16; discussion 416. PubMed ID: 22565043
[TBL] [Abstract][Full Text] [Related]
35. Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report.
Chotivichit A; Ruangchainikom M; Chiewvit P; Wongkajornsilp A; Sujirattanawimol K
J Med Case Rep; 2015 Apr; 9():79. PubMed ID: 25885347
[TBL] [Abstract][Full Text] [Related]
36. Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis.
De Marchi F; Mareschi K; Ferrero I; Cantello R; Fagioli F; Mazzini L
Cytotherapy; 2023 Aug; 25(8):798-802. PubMed ID: 36931995
[TBL] [Abstract][Full Text] [Related]
37. Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.
Harris VK; Vyshkina T; Sadiq SA
Cytotherapy; 2016 Dec; 18(12):1476-1482. PubMed ID: 27727015
[TBL] [Abstract][Full Text] [Related]
38. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
[TBL] [Abstract][Full Text] [Related]
39. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis.
Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Boccaletti R; Testa L; Livigni S; Fagioli F
Neurol Res; 2006 Jul; 28(5):523-6. PubMed ID: 16808883
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial.
Harris VK; Stark J; Williams A; Roche M; Malin M; Kumar A; Carlson AL; Kizilbash C; Wollowitz J; Andy C; Gerber LM; Sadiq SA
Stem Cell Res Ther; 2024 May; 15(1):151. PubMed ID: 38783390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
